Literature DB >> 21535252

Cutaneous epitheliotropic T-cell lymphoma in the cat: a review of the literature and five new cases.

Jacques Fontaine1, Marianne Heimann, Michael J Day.   

Abstract

Cutaneous epitheliotropic T-cell lymphoma (CETL) is characterized by cutaneous infiltration of neoplastic T lymphocytes with a specific tropism for the epidermis and adnexal epithelium. This disease is reported very rarely in the cat. Clinical data were collected from an informal discussion with veterinary dermatologists through the Vetdermlist (vetderm@lists.ncsu.edu). In parallel, case archives of two European diagnostic histopathology laboratories (Institut de Pathologie et Génétique/Bio.be Gosselies, Belgium and the School of Veterinary Sciences, University of Bristol, UK) were reviewed. Fifteen cases with a good clinical description were selected, and five sets of skin biopsies were available for review. Cutaneous epitheliotropic T-cell lymphoma generally affects older cats with no apparent sex or breed predisposition. Solitary or multiple lesions were reported without predilection for any particular location. The lesions consisted of erythematous plaques or patches, scaly alopecic patches and nonhealing ulcers or nodules, which sometimes mimicked an eosinophilic plaque. Pruritus was rarely reported. No lesions affecting the oral mucosa were observed. Clinical diagnosis of CETL is more challenging in cats than in dogs. Final diagnosis must be based on histopathological examination of skin biopsy samples. The characteristic lesions of feline CETL are similar to those reported in the dog, but involvement of the adnexal glands was not observed in this series (n=5). The neoplastic T cells were generally small to medium in size. The survival time of cats with CETL seems to be more variable than that of affected dogs. Too few cases have been evaluated to permit clear recommendations to be made with respect to treatment.
© 2011 The Authors. Veterinary Dermatology. © 2011 ESVD and ACVD.

Entities:  

Mesh:

Year:  2011        PMID: 21535252     DOI: 10.1111/j.1365-3164.2011.00972.x

Source DB:  PubMed          Journal:  Vet Dermatol        ISSN: 0959-4493            Impact factor:   1.589


  7 in total

1.  Cutaneous lymphoid hyperplasia mimicking cutaneous lymphoma in a hyperthyroid cat.

Authors:  Elisabeth Snead; Moira Kerr; Valerie Macdonald
Journal:  Can Vet J       Date:  2013-10       Impact factor: 1.008

Review 2.  Cutaneous epitheliotropic lymphoma in a baboon (Papio spp.): A case report and a brief literature review.

Authors:  Elvira Carias; Megan DeLorenzo; Michael Owston; Olga Gonzalez; Shyamesh Kumar; Edward J Dick
Journal:  J Med Primatol       Date:  2019-04-02       Impact factor: 0.667

3.  Cutaneous epitheliotropic T-cell lymphoma in a donkey - a case report.

Authors:  Jevgenija Kondratjeva; Florie Julien; Céline Coutelier; Louis Humeau; Fabien Moog; Daniel Combarros; Isabelle Fourquaux; Charline Pressanti; Maxence Delverdier; Peter F Moore; Marie Christine Cadiergues
Journal:  BMC Vet Res       Date:  2022-07-11       Impact factor: 2.792

4.  Multifocal cutaneous non-epitheliotropic B-cell lymphoma in a cat.

Authors:  Fausto Quintavalla; Rosanna Di Lecce; Daniele Carlini; Matteo Zanfabro; Anna M Cantoni
Journal:  JFMS Open Rep       Date:  2020-12-16

5.  Cutaneous epitheliotropic lymphosarcoma in a captive white catfish (Ameiurus catus Linnaeus).

Authors:  Ashlyn C Heniff; Laura R Chen; Emily F Christiansen; Craig A Harms; Jerry M Law; Christian Legner; Keith E Linder
Journal:  J Fish Dis       Date:  2022-04-27       Impact factor: 2.580

6.  Cutaneous non-epitheliotropic T-cell lymphoma associated with a fracture site in a cat.

Authors:  Selvi Jegatheeson; Julie Wayne; Laura K Brockley
Journal:  JFMS Open Rep       Date:  2018-03-09

7.  Feline and Canine Cutaneous Lymphocytosis: Reactive Process or Indolent Neoplastic Disease?

Authors:  Francesco Albanese; Francesca Abramo; Michele Marino; Maria Massaro; Laura Marconato; Lucia Minoli; Valeria Martini; Luca Aresu
Journal:  Vet Sci       Date:  2022-01-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.